Chronic Kidney Disease Trial, Recruiting (NCT07186218)

Chronic Kidney Disease Trial, Recruiting NCT07186218 Sponsor: Massachusetts General Hospital Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07186218 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older
People with advanced chronic kidney disease, meaning their kidneys are working at a low level — confirmed by at least two blood tests taken at least 90 days apart within the past 12 months, both showing kidney function at or below a certain threshold
People who are able to give their agreement to take part in the study
People who can read and write in English
People who are already receiving care from a kidney specialist (nephrologist) at a Mass General Brigham nephrology clinic

Who may not be able to join:

People with a serious illness that doctors expect may lead to death within 6 months
People who are already on dialysis, or for whom dialysis is scheduled to begin within the next 4 weeks
People who have a kidney transplant scheduled within the next 6 months
People who are attending the clinic for the very first time (first-ever visit to that clinic)
People who have cognitive difficulties that would make it hard to understand the consent form or study questionnaires

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617-726-5050

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07186218

Sponsor: Massachusetts General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 617-726-5050

More information: https://clinicaltrials.gov/study/NCT07186218

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older
People with advanced chronic kidney disease, meaning their kidneys are working at a low level — confirmed by at least two blood tests taken at least 90 days apart within the past 12 months, both showing kidney function at or below a certain threshold
People who are able to give their agreement to take part in the study
People who can read and write in English
People who are already receiving care from a kidney specialist (nephrologist) at a Mass General Brigham nephrology clinic

Who may not be able to join:

People with a serious illness that doctors expect may lead to death within 6 months
People who are already on dialysis, or for whom dialysis is scheduled to begin within the next 4 weeks
People who have a kidney transplant scheduled within the next 6 months
People who are attending the clinic for the very first time (first-ever visit to that clinic)
People who have cognitive difficulties that would make it hard to understand the consent form or study questionnaires

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Massachusetts General Hospital

Registry

ClinicalTrials.gov

Start date

11 June 2026

Est. completion

1 July 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reach (Implementation); Screen-eligibility; Reach (Implementation); Rate of consenting; Feasibility (Implementation); symptom survey completion rate; Feasibility (Implementation); Symptom documentation; Feasibility (Implementation); Interviews; Acceptability (Implementation); Interviews

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov